Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Osada

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Materials (Basel, Switzerland)|February 26, 2025
Giant Seebeck Effect in a PEDOT Material Coated on a Felt FiberHideki Arimatsu, Yuki Osada, Ryo Takagi, et al.
Polymers|October 23, 2021
First-Principle Study on p-n Control of PEDOT-Based Thermoelectric Materials by PTSA DopingHideki Arimatsu, Yuki Osada, Ryo Takagi, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|March 3, 2026
Worsening Heart Failure due to AV Dissociation From Safety Mode in CRT-P: A Case Requiring Urgent Generator ReplacementYuki Osada, Nobuhiko Ueda, Toshihiro Nakamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2024
[Safety and efficacy of 7-day administration of azacitidine and venetoclax combination therapy (7+7 therapy)]Yuki Osada, Hikari Kanai-Sudo, Taro Mizuki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 4, 2026
[Pure red cell aplasia in a patient with cold agglutinin disease-associated lymphoproliferative disorder]Makiko Ogawa, Yuki Osada, Aina Tomori, et al.
Medical Oncology (Northwood, London, England)|March 24, 2017
Association between a cardiovascular disease risk assessment and the molecular response to tyrosine kinase inhibitors in chronic-phase chronic myeloid leukemia patientsYuki Osada, Hideki Arakaki, Satoshi Takanashi, et al.
Annals of Hematology|May 17, 2017
Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphomaHideki Arakaki, Tomonori Nakazato, Yuki Osada, et al.
Materials (Basel, Switzerland)|February 13, 2025
Dual Roles of PTSA in Electrical Conductivity of PEDOT:PTSA with Large Seebeck CoefficientHideki Arimatsu, Yuki Osada, Ryo Takagi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 5, 2025
[Good's syndrome complicated with pure white cell aplasia]Yukiko Nishizaki, Yuki Osada, Hikari Kanai-Sudo, et al.
Annals of Hematology|May 2, 2018
A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatmentYuriko Fujita, Tomonori Nakazato, Chisako Ito, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Materials (Basel, Switzerland)|February 26, 2025
Giant Seebeck Effect in a PEDOT Material Coated on a Felt FiberHideki Arimatsu, Yuki Osada, Ryo Takagi, et al.
Polymers|October 23, 2021
First-Principle Study on p-n Control of PEDOT-Based Thermoelectric Materials by PTSA DopingHideki Arimatsu, Yuki Osada, Ryo Takagi, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|March 3, 2026
Worsening Heart Failure due to AV Dissociation From Safety Mode in CRT-P: A Case Requiring Urgent Generator ReplacementYuki Osada, Nobuhiko Ueda, Toshihiro Nakamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2024
[Safety and efficacy of 7-day administration of azacitidine and venetoclax combination therapy (7+7 therapy)]Yuki Osada, Hikari Kanai-Sudo, Taro Mizuki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 4, 2026
[Pure red cell aplasia in a patient with cold agglutinin disease-associated lymphoproliferative disorder]Makiko Ogawa, Yuki Osada, Aina Tomori, et al.
Medical Oncology (Northwood, London, England)|March 24, 2017
Association between a cardiovascular disease risk assessment and the molecular response to tyrosine kinase inhibitors in chronic-phase chronic myeloid leukemia patientsYuki Osada, Hideki Arakaki, Satoshi Takanashi, et al.
Annals of Hematology|May 17, 2017
Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphomaHideki Arakaki, Tomonori Nakazato, Yuki Osada, et al.
Materials (Basel, Switzerland)|February 13, 2025
Dual Roles of PTSA in Electrical Conductivity of PEDOT:PTSA with Large Seebeck CoefficientHideki Arimatsu, Yuki Osada, Ryo Takagi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 5, 2025
[Good's syndrome complicated with pure white cell aplasia]Yukiko Nishizaki, Yuki Osada, Hikari Kanai-Sudo, et al.
Annals of Hematology|May 2, 2018
A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatmentYuriko Fujita, Tomonori Nakazato, Chisako Ito, et al.
Pageof 2